A new vaccine to tackle gum disease is in development.
A new vaccine to help tackle gum disease is being developed in Australia. 
Pharmaceutical company CSL has been working with researchers from universities across the country to help create a vaccine that could help reverse the effects of gum disease, as well as stopping its development in the first place.
“Periodontitis is a serious disease and dentists face a major challenge treating it, because most people will not know they have the disease until it’s too late,” Professor Eric Reynolds of the University of Melbourne commented.
Dr Andrew Cuthbertson, CSL’s chief scientific officer, noted work on this new inoculation has been underway for the last ten years and has now reached the phase where it will be tested on mice, with human trials the next step.
Elsewhere, research carried out at the New York University recently revealed a link between gum disease and diabetes.
The study found 90 per cent of patients who have gum disease are at high risk of developing the illness.